Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
filingDate |
2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_438d97f2817a142642c3f0eaf083ede3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99bfab467157549bf8399b840bbf0394 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0de287bf8316cfd0f70a0da8de05e1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeae06b0a7192ed20623b56b556c2f28 |
publicationDate |
2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007021825-A1 |
titleOfInvention |
Local Delivery of Rapamycin for Treatment of Proliferative Sequelae Associated with PTCA Procedures, Including Delivery Using a Modified Stent |
abstract |
Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015157615-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10182928-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010035044-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844601-B2 |
priorityDate |
1997-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |